Prolific Machines is a biotech company developing cell technologies to redefine how cells are produced for a sustainable and healthy future.
Prolific Machines is a biotech company developing cell technologies to redefine how cells are produced for a sustainable and healthy future. It combines cutting-edge technologies to enable cell production at a new scale. The company was founded in 2020 and is based in San Francisco, California.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 7, 2022 | Convertable Note | — | 2 | — | — | Detail |
| Sep 14, 2022 | Series A | $42M | 12 |
Breakthrough Energy Ventures
|
— | Detail |
| Nov 19, 2021 | Seed | — | 1 | — | — | Detail |
| Mar 22, 2021 | Seed | — | 2 | — | — | Detail |
| Jul 14, 2020 | Convertable Note | — | 1 | — | — | Detail |
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Breakthrough Energy Ventures
|
Yes | Series A |
IndieBio
|
— | Convertable Note |
SOSV
|
— | Convertable Note |
Baruch Future Ventures
|
— | Series A |
Breyer Capital
|
— | Series A |
David Adelman
|
— | Series A |
David Rubenstein
|
— | Series A |
Frederick Blackford
|
— | Series A |
Jacob Poliskin
|
— | Series A |
Mark Cuban
|
— | Series A |